Where does GlaxoSmithKline Intellectual Property Management Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), GlaxoSmithKline Intellectual Property Management Limited ranks #28,865 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Is GlaxoSmithKline Intellectual Property Management Limited's patent grant rate increasing or decreasing?

GlaxoSmithKline Intellectual Property Management Limited's recent grant velocity is +200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for GlaxoSmithKline Intellectual Property Management Limited's patents?

GlaxoSmithKline Intellectual Property Management Limited's patents average 12.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

GlaxoSmithKline Intellectual Property Management Limited

Q: How many patents does GlaxoSmithKline Intellectual Property Management Limited hold?

GlaxoSmithKline Intellectual Property Management Limited holds 9 US utility patents granted between 2017 and 2025, spanning 7 technology areas.

Q: What is GlaxoSmithKline Intellectual Property Management Limited's Innovation Score?

GlaxoSmithKline Intellectual Property Management Limited has an Innovation Score of 29.5 out of 100 (31st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Q: What technology areas does GlaxoSmithKline Intellectual Property Management Limited focus on?

GlaxoSmithKline Intellectual Property Management Limited's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 5 patents. Grants appear in 7 CPC subclasses total.

Q: How is the GlaxoSmithKline Intellectual Property Management Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 9 granted patents across 7 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Glaxosmithkline ranks #28,865 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 7 technology areas.

#28,865
of 49,997 US assignees by volume: 31st percentile
by Innovation Score (29.5/100): 12.0
avg claims per patent: +200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R28865 · Foreign Corporation #28,865 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #28,865/49,997
PHOTO-FINISH Gideon Brothers d o o
CPC-NARROW A61P · 7 areas
INNOV-THIN 29.5/100
CLAIMS-RICH 12.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Gideon Brothers d.o.o. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
GlaxoSmithKline… · this assignee

30
3D Lighting… · lowest

7

What this shows Glaxosmithkline's Innovation Score is 29.5/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Glaxosmithkline's grants concentrate

GlaxoSmithKline Intellectual Property Management Limited is a focused PatentsView assignee: 7 CPC subclasses with 55.6% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2017. By volume, Glaxosmithkline sits between Gideon Brothers d.o.o. and GoNow Technologies, LLC.

Glaxosmithkline's three-year grant acceleration

GlaxoSmithKline Intellectual Property Management Limited shows 3 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Gideon Brothers d…

9
Gigadevice Semico…

9
Gilead Biologics

9
Glatt Gesellschaf…

9
Glencore Technolo…

9
Global Cooling

9
Globe Internation…

9
Gonow

9
Glaxosmithkline I… ◀

9

What this shows GlaxoSmithKline holds 9 patents at rank #28,882, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near GlaxoSmithKline

By rank, the assignees closest to #28,882 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in GlaxoSmithKline's primary technology class.

Glaxosmithkline's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 31st percentile higher than 31% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

GlaxoSmithKline Intellectual Property Management Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	11.1%
2019	1	11.1%
2020	1	11.1%
2021	2	22.2%
2022	1	11.1%
2023	1	11.1%
2024	1	11.1%
2025partial year	1	11.1%

Which technologies does GlaxoSmithKline Intellectual Property Management Limited patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

C07K - Peptides 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

G09F - DISPLAYING; ADVERTISING; SIGNS; Labels OR NAME-PLATES; Seals 1

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

B65C - Labelling OR Tagging Machines, Apparatus, OR Processes 1

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 1

Top 7 of 7 technology areas

Where it ranks

Overall rank by patents

#28,865

of 49,997 tracked assignees

Innovation Score

29.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

GlaxoSmithKline Intellectual Property Management Limited's patent record in context - here's where to go next.

GlaxoSmithKline Intellectual Property Management Limited's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 55.6% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #28,865 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare GlaxoSmithKline Intellectual Property Management Limited against Gideon Brothers d.o.o., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.